Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
65.06B
Market cap65.06B
Price-Earnings ratio
25.35
Price-Earnings ratio25.35
Dividend yield
0.70%
Dividend yield0.70%
Average volume
1.15M
Average volume1.15M
High today
$342.94
High today$342.94
Low today
$339.01
Low today$339.01
Open price
$342.80
Open price$342.80
Volume
1.83M
Volume1.83M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

Cencora, Inc.(COR) stock is priced at $340.92, giving the company a market capitalization of 65.06B. It carries a P/E multiple of 25.35 and pays a dividend yield of 0.70%.

On 2026-10-18, Cencora, Inc.(COR) stock moved within a range of $339.01 to $342.94. With shares now at $340.92, the stock is trading +0.6% above its intraday low and -0.6% below the session's peak.

Trading volume for Cencora, Inc.(COR) stock has reached 1.83M, versus its average volume of 1.15M.

Over the past 52 weeks, Cencora, Inc.(COR) stock has traded between a high of $377.54 and a low of $244.82.

Over the past 52 weeks, Cencora, Inc.(COR) stock has traded between a high of $377.54 and a low of $244.82.

COR News

Simply Wall St 1d
Will Raised EPS Guidance Change Cencora Stock Narrative

Cencora recently raised its fiscal 2026 EPS guidance, reflecting confidence in the earnings contribution from acquisitions such as OneOncology and the pharmaceu...

Will Raised EPS Guidance Change Cencora Stock Narrative
TipRanks 2d
Cencora price target lowered to $400 from $430 at UBS

UBS lowered the firm’s price target on Cencora (COR) to $400 from $430 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source fo...

MarketWatch 5d
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch

Analyst ratings

59%

of 17 ratings
Buy
58.8%
Hold
41.2%
Sell
0%

More COR News

Simply Wall St 6d
Cencora Has Investors Asking A Bigger Question

Advertisement How Cencora Stock Has Been Trading Recently Cencora (COR) has been moving on fundamentals rather than a single headline catalyst, with recent tr...

Cencora Has Investors Asking A Bigger Question

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.